z-logo
open-access-imgOpen Access
GDNF treatment in Parkinson's disease: time for controlled clinical trials?
Author(s) -
P. Brundin
Publication year - 2002
Publication title -
brain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.142
H-Index - 336
eISSN - 1460-2156
pISSN - 0006-8950
DOI - 10.1093/brain/awf217
Subject(s) - glial cell line derived neurotrophic factor , neuroscience , neurotrophic factors , clinical trial , parkinson's disease , mptp , medicine , putamen , dopamine , dopaminergic , disease , psychology , pathology , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom